Merrimack Pharmaceuticals Company
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2000
Employees Number:
251-500
Funding Status:
IPO
Total Funding:
288013000
Estimated Revenue:
Less than $1M
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership